Sign Up to like & get
recommendations!
0
Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32150
Abstract: Cholangiocarcinoma is a deadly and highly therapy-refractory cancer of the bile ducts, with early results from immune checkpoint blockade trials showing limited responses. While recent molecular assessments have made bulk characterizations of immune profiles and…
read more here.
Keywords:
immune checkpoint;
immunogenomic landscape;
intrahepatic cholangiocarcinoma;
resected intrahepatic ... See more keywords